2seventy bio (TSVT)
NASDAQ:TSVT
US Market
Holding TSVT?
Track your performance easily

2seventy bio (TSVT) Financial Statements

253 Followers

2seventy bio Financial Overview

2seventy bio's market cap is currently ―. The company's EPS TTM is $-3.064; its P/E ratio is -1.65; 2seventy bio is scheduled to report earnings on November 27, 2024, and the estimated EPS forecast is $-0.27. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Dec 23Sep 23Jun 23Mar 23
Income Statement-
Total Revenue$ 8.97M$ 10.68M$ 12.03M$ 5.02M$ 12.25M
Gross Profit$ 5.51M$ 7.54M$ 7.08M$ 9.72M$ 7.95M
EBIT$ -20.36M$ -59.88M$ -57.24M$ -42.09M$ -47.02M
EBITDA$ -18.68M$ -56.85M$ -54.48M$ -39.85M$ -44.77M
Net Income Common Stockholders$ 24.88M$ -56.82M$ -71.64M$ -42.09M$ -47.02M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 201.87M$ 216.99M$ 250.62M$ 282.84M$ 193.63M
Total Assets$ 517.90M$ 565.43M$ 640.81M$ 705.71M$ 742.44M
Total Debt$ 251.40M$ 256.67M$ 260.16M$ 263.58M$ 414.69M
Net Debt$ 49.52M$ 39.68M$ 9.54M$ -19.26M$ 221.06M
Total Liabilities$ 283.09M$ 310.13M$ 334.38M$ 338.22M$ 341.11M
Stockholders Equity$ 234.80M$ 255.30M$ 306.42M$ 367.50M$ 401.32M
Cash Flow-
Free Cash Flow$ -23.18M$ -64.67M$ -24.18M$ -36.70M$ -55.22M
Operating Cash Flow$ -23.12M$ -63.60M$ -21.43M$ -32.73M$ -49.14M
Investing Cash Flow$ 78.44M$ 47.89M$ 15.93M$ -64.83M$ 44.87M
Financing Cash Flow$ -24.00K$ 253.00K$ -75.00K$ 128.00K$ 127.08M
Currency in USD

2seventy bio Earnings and Revenue History

2seventy bio Debt to Assets

2seventy bio Cash Flow

2seventy bio Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis